Class I and class II MHC polymorphisms in Mexican patients with Behcet's disease

被引:24
|
作者
Soto-Vega, E
García-Muñoz, R
Richaud-Patin, Y
Zúñiga-Ramos, J
Crispín, JC
Díaz-Jouanen, E
Flores-Suárez, LF
Llorente, L
Granados, J
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico
[2] Inst Nacl Enfermedades Resp, Infect Dis Unit, Mexico City 14080, DF, Mexico
[3] Hosp Angeles Lomas, Dept Med, Huixquilucan 52763, Edo Mexico, Mexico
关键词
HLA-B; HLA-DR; Behcet's disease; genetic susceptibility; Mexican Mestizos;
D O I
10.1016/j.imlet.2004.03.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Behcet's disease is a multi-system inflammatory disorder of unknown etiology. The disease is more prevalent in Eastern Mediterranean countries and Japan where there is a linkage to HLA-B51. Mexican Mestizos are suitable subjects for studying the role of ethnicity in the susceptibility to Behcet's disease. High-resolution HLA class I and class II typing was performed by polymerase chain reaction sequence-specific oligonucleotide (PCR-SSO) reverse dot blot and PCR-single-strand polymorphism in 32 patients with Behcet's disease and 99 healthy ethnically-matched controls. A significant increased frequency of HLA-B*44 (P = 0.02; OR 2.78; CI 95% = 1.1-7.7), HLA-B*52 (P = 0.02; OR = 5.33; Cl 95% = 1.07-29.1), and HLA-B*56 (P = 0.003; OR = 4.19; Cl 95% 3.37-5.21) as well as HLA-DRB1*01 and HLA-DRB1*13 (P = 0.007; OR = 3.36; Cl 95% = 1.22-9.27) was found in Mexican patients with Behcet's disease when compared to controls. The low frequency of native markers in Mexican Mestizo patients with Behcet's disease suggests that genetic admixture between Eastern Mediterraneans and Orientals with Amerindians is a recent event that increased the risk of developing Behcet's disease in the Mexican population. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 50 条
  • [21] MOLECULAR ANALYSIS OF MHC CLASS I AND CLASS II ALLELES IN ACUTE MYELOID LEUKEMIA IN MEXICAN MESTIZO POPULATION
    Gorodezky, Clara
    Flores, Hilario
    Alaez, Carmen
    Munguia, Andrea
    Valencia, Miriam
    Sanchez, Diego
    Rodriguez, Araceli
    Manzanares, Felicitas
    TISSUE ANTIGENS, 2015, 85 (05): : 338 - 338
  • [22] INTRODUCTION TO MHC (CLASS-I-CLASS-II) - METHODS
    FAUCHET, R
    ANNALES DE RECHERCHES VETERINAIRES, 1989, 20 (03): : 329 - 336
  • [23] MHC class I and class II genes in Tunisian patients with reactive and undifferentiated arthritis
    Siala, M.
    Mahfoudh, N.
    Fourati, H.
    Gdoura, R.
    Younes, M.
    Kammoun, A.
    Chour, I.
    Meddeb, N.
    Gaddour, L.
    Hakim, F.
    Baklouti, S.
    Bargaoui, N.
    Sellami, S.
    Hammami, A.
    Makni, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 208 - 213
  • [24] Peptide binding by class I and class II MHC molecules
    Batalia, MA
    Collins, EJ
    BIOPOLYMERS, 1997, 43 (04) : 281 - 302
  • [25] Peptide binding by class I and class II MHC molecules
    Batalia, M.A.
    Collins, E.J.
    Biopolymers - Peptide Science Section, 1997, 43 (04): : 281 - 302
  • [26] Prospective multicentre study on MHC class I and class II polymorphisms in children with Guillain-Barre syndrome
    Kirschner, J
    Korinthenberg, RK
    Pahl, A
    Blasczyk, R
    Luther, B
    Mauff, G
    NEUROMUSCULAR DISORDERS, 2002, 12 (7-8) : 774 - 774
  • [28] MHC class II and III polymorphisms and the Antiphospholipid Syndrome
    Galli, M
    THROMBOSIS AND HAEMOSTASIS, 2001, 85 (02) : 193 - 194
  • [29] Towards a systems understanding of MHC class I and MHC class II antigen presentation
    Neefjes, Jacques
    Jongsma, Marlieke L. M.
    Paul, Petra
    Bakke, Oddmund
    NATURE REVIEWS IMMUNOLOGY, 2011, 11 (12) : 823 - 836
  • [30] Towards a systems understanding of MHC class I and MHC class II antigen presentation
    Jacques Neefjes
    Marlieke L. M. Jongsma
    Petra Paul
    Oddmund Bakke
    Nature Reviews Immunology, 2011, 11 : 823 - 836